NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS
Go back to NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS| (NASDAQ: NRSN) | Delayed: 0.71 -0.01 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $ | |||
| Open | $0.75 | 52 Week Low | $ | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.67 | EPS | $ | |||
| Volume | 231,788 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.07 | 52 Week High | $ | |||
| Open | $0.07 | 52 Week Low | $ | |||
| Day High | $0.07 | P/E | N/A | |||
| Day Low | $0.07 | EPS | $ | |||
| Volume | 6 | |||||

